EP. 1: AEs from Novel Hormone Therapy in Nonmetastatic Castrate Resistant Prostate Cancer
In Urology Times’ monthly installment of Around the Practice, experts discuss adverse event management from various treatments for prostate and bladder cancer.
EP. 2: AEs from PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer
EP. 3: AEs from Immunotherapy monotherapy for BCG-Unresponsive NMIBC
2 Clarke Drive Cranbury, NJ 08512